Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage

Stroke; a Journal of Cerebral Circulation
D W NibbelinkW G Henderson

Abstract

In this cooperative study among 13 institutions, 502 patients were treated with antifibrinolytic medication (epsilon-aminocaproic acid or tranexamic acid) within a 14-day period following rupture of an intracranial aneurysm. Mortality at the end of 14 days was 11.6%; proved rebleed rate was 12.7%. Patients with an internal carotid or anterior cerebral aneurysm had the highest mortality and rebleed rate. Most rebleeds occurred between the sixth and eleventh days following the initial bleed. Significantly higher mortality was reported among patients with cerebral vasospasm, yet rebleed rate was no different among those patients with or without vasospasm. The same pattern was observed among patients with a mean blood pressure value above and below 110 mm Hg. We conclude that antifibrinolytic therapy provides beneficial treatment to patients with recent onset subarachnoid hemorrhage (SAH) following rupture of an intracranial aneurysm.

References

Dec 1, 1972·Journal of Neurosurgery·H A KrayenbühlJ M Tew
Jan 1, 1973·Archives of Neurology·K K WuJ C Hoak
Apr 1, 1974·Journal of Neurosurgery·R GeronemusK Shulman
Feb 1, 1972·Journal of Neurosurgery·J L Pool
Nov 1, 1966·The Medical Clinics of North America·J J Bergin
Jan 1, 1968·Journal of Neurosurgery·S Mullan, J Dawley
May 1, 1969·Neurochirurgia·G Norlén, C A Thulin

❮ Previous
Next ❯

Citations

Jan 1, 1987·Journal of Neurology·K W Lindsay
Dec 1, 1983·Italian Journal of Neurological Sciences·G GalassiA Colombo
Apr 4, 2008·Neurocritical Care·Mark ChwajolE Sander Connolly
Sep 1, 1994·Journal of the Neurological Sciences·J P Weaver, M Fisher
Jan 1, 1980·Clinical Neurology and Neurosurgery·H van Crevel
Jan 1, 1980·Clinical Neurology and Neurosurgery·M Vermeulen, J P Muizelaar
Jan 1, 1984·Clinical Neurology and Neurosurgery·D Van RenterghemM Van der Straeten
Jan 1, 1990·Clinical Neurology and Neurosurgery·E F WijdicksJ van Gijn
Mar 17, 1983·The New England Journal of Medicine·G S AllenC R Transou
Mar 18, 2006·Current Opinion in Critical Care·Oliver W Sakowitz, Andreas W Unterberg
Aug 19, 1978·British Medical Journal·J Van Rossum, A R Wintzen
Apr 23, 1983·British Medical Journal·E R Hitchcock
May 1, 1978·Journal of Clinical Pathology·M AndersonJ Stuart
Feb 1, 1980·Journal of Neurology, Neurosurgery, and Psychiatry·R S Maurice-WilliamsA Sykes
Mar 1, 1981·Journal of Neurology, Neurosurgery, and Psychiatry·A A Ameen, R Illingworth
Feb 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·S A Tsementzis, E R Hitchcock
Jun 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·M Vermeulen, G J Rinkel
Oct 1, 1978·Journal of Neurosurgery·A R MacKayP R Weinstein
Jan 1, 1981·Journal of Neurosurgery·S Wessler, S N Gitel
Jun 1, 1981·Journal of Neurosurgery·S S FishR Berkseth
Feb 1, 1982·Journal of Neurosurgery·H Hugenholtz, R G Elgie
Jul 1, 1982·Journal of Neurosurgery·J A BrownS Mullan
Sep 1, 1987·Journal of Neurosurgery·J RosenørnF Rønde
Dec 3, 2014·Neurologia i neurochirurgia polska·Gobran Taha Ahmed AlfotihShangYi Zhang
Jan 1, 1990·Acta neurochirurgica·S A TsementzisC H Meyer
Jan 1, 1980·Acta neurochirurgica·P RasmussenL Hansen
Jan 1, 1992·British Journal of Neurosurgery·P O'NeillM D Shaw
Jan 1, 1988·British Journal of Neurosurgery·J RosenørnK Schmidt
Feb 1, 1984·Surgical Neurology·D Parkinson, S Stephensen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.